FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alessio Nencioni

Research Profile

Anatomy

Chemicals & Drugs

Physiology

Living Beings

Mouse

Disorders

Co-author Network

Publications

TOP 3
Fabrizio Montecucco; Aimable Nahimana; Debora Soncini; Antonio Uccelli; Inga Bauer; Santina Bruzzone; Irene Caffa; Michele Cea; Denise Lasigliè; Alessio Nencioni
Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience.
F Carbone; François Mach; Alessio Nencioni; N Vuilleumier; Fabrizio Montecucco
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases.
Michele Cea; Marco Gobbi; Alessio Nencioni; Franco Patrone; Antonia Cagnetta; Kenneth C Anderson
Intracellular NAD(+) depletion induces autophagic death in multiple myeloma cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alessio Nencioni (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Fabrizio Montecucco; Aimable Nahimana; Debora Soncini; Antonio Uccelli; Inga Bauer; Santina Bruzzone; Irene Caffa; Michele Cea; Denise Lasigliè; Alessio Nencioni
Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience.
Current drug targets 2013;14(6):637-43.
2013: F Carbone; François Mach; Alessio Nencioni; N Vuilleumier; Fabrizio Montecucco
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases.
Thrombosis and haemostasis 2013;109(5):854-68.
2013: Michele Cea; Marco Gobbi; Alessio Nencioni; Franco Patrone; Antonia Cagnetta; Kenneth C Anderson
Intracellular NAD(+) depletion induces autophagic death in multiple myeloma cells.
Autophagy 2013;9(3):410-2.
2013: Fabrizio Montecucco; Christophe Montessuit; Raul Mostoslavsky; Franco Patrone; Graziano Pelli; Corinne Pellieux; Alessandro Poggi; Carlos Sebastian; Timo Speer; Nicolas Vuilleumier; Alexander Akhmedov; Inga Bauer; Maria Bertolotto; Vincent Braunersreuther; Santina Bruzzone; Franco Dallegri; Katia Galan; Anna Garuti; Angèle Gayet-Ageron; Sébastien Lenglet; René Lerch; Thomas F Lüscher; François Mach; Jacqueline Mage; Elena Mannino; Alessio Nencioni
Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction.
Antioxidants & redox signaling 2013;18(6):630-41.
2013: Michele Cea; Gabriella Cirmena; Anna Garuti; Marco Gobbi; Alessio Nencioni; Claudia Palermo; Alberto Ballestrero; Antonia Cagnetta; Angelo Michele Carella; Ivana Pierri; Daniele Reverberi; Ilaria Rocco; Franco Patrone
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status.
Leukemia & lymphoma 2013;54(2):342-52.
2013: Alessandra Puddu; Giorgio Luciano Viviani; François Mach; Alessio Nencioni; Fabrizio Montecucco
An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes.
Mediators of inflammation 2013;2013():591056.
2013: Mohamed Asrih; Franco Dallegri; François Mach; Alessio Nencioni; Alessandra Quercioli; Fabrizio Montecucco
Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome.
Mediators of inflammation 2013;2013():367245.
2013: Santina Bruzzone; Alberto Del Rio; Alessia Grozio; Alberto Ballestrero; Inga Bauer; Marco Daniele Parenti; Alessio Nencioni
Rejuvenating sirtuins: the rise of a new family of cancer drug targets.
Current pharmaceutical design 2013;19(4):614-23.
2012: Inga Bauer; Santina Bruzzone; Irene Caffa; Michele Cea; Georg Feldmann; Alessia Grozio; Denise Lasigliè; Mirko Magnone; Raul Mostoslavsky; Franco Patrone; Alessandro Poggi; Giovanna Sociali; Debora Soncini; Laura Sturla; Gabriele Zoppoli; Alberto Ballestrero; Giovanna Basile; Alessio Nencioni
The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses.
The Journal of biological chemistry 2012;287(49):40924-37.
2012: Michele Cea; Dharminder Chauhan; Francesca Cottini; Mariateresa Fulciniti; Marco Gobbi; Teru Hideshima; Jana Jakubikova; Sun-Young Kong; Nikhil Munshi; Alessio Nencioni; Franco Patrone; Paul Richardson; Aldo Roccaro; Antonio Sacco; Yu-Tzu Tai; Antonia Cagnetta; Teresa Calimeri; Kenneth C Anderson
Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition.
Blood 2012;120(17):3519-29.
2012: Eva Moran; Valeria Augusti; Alberto Ballestrero; Federico Carbone; Franco Patrone; Alessio Nencioni
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience.
Seminars in hematology 2012;49(3):270-6.
2012: Mirko Magnone; Elena Mannino; Alessio Nencioni; Alessandro Poggi; Laura Sturla; Elena Zocchi; Inga Bauer; Marisa Brini; Antonio De Flora; Santina Bruzzone
NAD+ levels control Ca2+ store replenishment and mitogen-induced increase of cytosolic Ca2+ by Cyclic ADP-ribose-dependent TRPM2 channel gating in human T lymphocytes.
The Journal of biological chemistry 2012;287(25):21067-81.
2012: Alberto Ballestrero; Gabriella Cirmena; Anna Garuti; Alessio Nencioni; Claudia Palermo; Stefano Parodi; Ilaria Rocco; S Scabini; G Zoppoli; Franco Patrone
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond.
Current cancer drug targets 2012;12(4):316-28.
2012: D Soncini; Franco Patrone; Alberto Ballestrero; I Caffa; Alessio Nencioni
Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer.
Current cancer drug targets 2012;12(4):329-38.
2012: Santina Bruzzone; Giuseppe Colombo; Renzo Cordera; Gianluca Damonte; Antonio De Flora; Daniela Fenoglio; Francesca Fiory; Alessia Grozio; Lucrezia Guida; Davide Maggi; Mirko Magnone; Elena Mannino; Claudia Miele; Giovanni Murialdo; Alessio Nencioni; Vittorio Ruvolo; Annalisa Salis; Sonia Scarfì; Laura Sturla; Pietro Ameri; Gabriella Andraghetti; Giovanna Basile; Francesco Beguinot; Mariano Bormioli; Lucia Briatore; Elena Zocchi
The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012;26(3):1251-60.
2011: Claudia Bello; Michele Cea; Giovanna Dal Bello; Michel A Duchosal; Marc Dupuis; Floriana Fruscione; Anna Garuti; Francesco Grossi; Jacqueline Loretan; Eva Moran; Giulia Motta; Aimable Nahimana; Alessio Nencioni; Franco Patrone; Paolo Pronzato; Bernard Sordat; Dominique Aubry; Alberto Ballestrero; Markus Wartmann; Kaspar Zimmermann; Pierre Vogel
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols.
Bioorganic & medicinal chemistry 2011;19(24):7720-7.
2011: Michele Cea; Gianluca Damonte; Laura Emionite; Floriana Fruscione; Anna Garuti; Marco Gobbi; Mirko Magnone; Eva Moran; Franco Patrone; Ivana Pierri; Vito Pistoia; Lizzia Raffaghello; Daniele Reverberi; Annalisa Salis; Debora Soncini; Gabriele Zoppoli; Filippo Ansaldi; Alberto Ballestrero; Micaela Bergamaschi; Santina Bruzzone; Irene Caffa; Antonia Cagnetta; Salvatore Casciaro; Alessio Nencioni
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells.
PloS one 2011;6(7):e22739.
2011: G Motta; Franco Patrone; V Augusti; F Carbone; M Cea; E Moran; Alessio Nencioni
Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2011;16(1):9-15.
2010: Gabriele Zoppoli; Michele Cea; Debora Soncini; Floriana Fruscione; Justine Rudner; Eva Moran; Irene Caffa; Davide Bedognetti; Giulia Motta; Riccardo Ghio; Fabio Ferrando; Alberto Ballestrero; Silvio Parodi; Claus Belka; Franco Patrone; Santina Bruzzone; Alessio Nencioni
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells.
Experimental hematology 2010;38(11):979-88.
2010: N Castagnino; L Tortolina; A Balbi; R Pesenti; R Montagna; Alberto Ballestrero; D Soncini; E Moran; Alessio Nencioni; S Parodi
Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments: concordance with experimental results.
Current cancer drug targets 2010;10(7):737-57.
2010: Michele Cea; Gabriella Cirmena; Anna Garuti; Ilaria Rocco; Claudia Palermo; Antonia Cagnetta; Eva Moran; Nicoletta Colombo; Raffaella Grasso; Giuseppina Fugazza; marco gobbi; Alessio Nencioni; Alberto Ballestrero; Franco Patrone
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.
Leukemia research 2010;34(9):e240-2.
2010: A Ballestrero; Gabriella Cirmena; Alida Dominietto; Anna Garuti; Ilaria Rocco; M Cea; E Moran; Alessio Nencioni; Maurizio Miglino; Anna Maria Raiola; Andrea Bacigalupo; Franco Patrone
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients.
International journal of laboratory hematology 2010;32(4):387-91.
2010: Gabriele Zoppoli; Eva Moran; Debora Soncini; Michele Cea; Anna Garuti; Ilaria Rocco; Gabriella Cirmena; Valentina Grillo; L Bagnasco; Giancarlo Icardi; Filippo Ansaldi; Silvio Parodi; Franco Patrone; Alberto Ballestrero; Alessio Nencioni
Ras-induced resistance to lapatinib is overcome by MEK inhibition.
Current cancer drug targets 2010;10(2):168-75.
2010: Giulia Motta; Michele Cea; Eva Moran; Federico Carbone; Valeria Augusti; Franco Patrone; Alessio Nencioni
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives.
Clinical & developmental immunology 2010;2010():428253.
2010: Alessio Nencioni; Michele Cea; Anna Garuti; Mario Passalacqua; Lizzia Raffaghello; Debora Soncini; Eva Moran; Gabriele Zoppoli; Vito Pistoia; Franco Patrone; Alberto Ballestrero
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression.
PloS one 2010;5(2):e9024.
2009: M Cea; A Cagnetta; Anna Garuti; Gabriella Cirmena; Ilaria Rocco; E Moran; V Grillo; Alberto Ballestrero; Franco Patrone; Alessio Nencioni
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2009;14(4):565-73.
2009: Santina Bruzzone; Floriana Fruscione; Sara Morando; Tiziana Ferrando; Alessandro Poggi; Anna Garuti; Agustina D'Urso; Martina Selmo; Federica Benvenuto; Michele Cea; Gabriele Zoppoli; Eva Moran; Debora Soncini; Alberto Ballestrero; Bernard Sordat; Franco Patrone; Raul Mostoslavsky; Antonio Uccelli; Alessio Nencioni
Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE.
PloS one 2009;4(11):e7897.
2008: Alessio Nencioni; Peter Brossart
Crosspresentation: a matter of pH.
Blood 2008;112(12):4368-9.
2008: Alessio Nencioni; Frank Grünebach; Susanne M Schmidt; Martin R Müller; Davide Boy; Franco Patrone; Alberto Ballestrero; Peter Brossart
The use of dendritic cells in cancer immunotherapy.
Critical reviews in oncology/hematology 2008;65(3):191-9.
2008: Alberto Ballestrero; Davide Boy; Eva Moran; Gabriella Cirmena; Peter Brossart; Alessio Nencioni
Immunotherapy with dendritic cells for cancer.
Advanced drug delivery reviews 2008;60(2):173-83.
2008: Alberto Ballestrero; Davide Boy; Roberta Gonella; Maurizio Miglino; Marino Clavio; Valentina Barbero; Alessio Nencioni; marco gobbi; Franco Patrone
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas.
Annals of hematology 2008;87(1):49-55.
2007: Eva Moran; Alessio Nencioni
The role of proteasome in malignant diseases.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2007;12 Suppl 1():S95-9.
2007: Alessio Nencioni; Julia Beck; Daniela Werth; Frank Grünebach; Franco Patrone; Alberto Ballestrero; Peter Brossart
Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(13):3933-41.
2007: Alessio Nencioni; Frank Grünebach; Franco Patrone; Alberto Ballestrero; Peter Brossart
Proteasome inhibitors: antitumor effects and beyond.
Leukemia 2007;21(1):30-6.
2006: Alessio Nencioni; Karin Schwarzenberg; Katharina M Brauer; Susanne M Schmidt; Alberto Ballestrero; Frank Grünebach; Peter Brossart
Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation.
Blood 2006;108(2):551-8.
2006: Alessio Nencioni; Anna Garuti; Karin Schwarzenberg; Gabriella Cirmena; Giovanna Dal Bello; Ilaria Rocco; Eleonora Barbieri; Peter Brossart; Franco Patrone; Alberto Ballestrero
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells.
European journal of immunology 2006;36(3):681-9.
2006: Alessio Nencioni; Frank Grunebach; Franco Patrone; Alberto Ballestrero; Peter Brossart
The proteasome and its inhibitors in immune regulation and immune disorders.
Critical reviews in immunology 2006;26(6):487-98.
2005: Alessio Nencioni; Lucia Wille; Giovanna Dal Bello; Davide Boy; Gabriella Cirmena; Sebastian Wesselborg; Claus Belka; Peter Brossart; Franco Patrone; Alberto Ballestrero
Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4259-65.
2005: Alberto Ballestrero; Anna Garuti; M Bertolotto; Ilaria Rocco; Davide Boy; Alessio Nencioni; Luciano Ottonello; Franco Patrone
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer.
British journal of cancer 2005;92(10):1948-52.
2005: Alessio Nencioni; Fei Hua; Christopher P Dillon; Rayka Yokoo; Christoph A. Scheiermann; Mike H Cardone; Eleonora Barbieri; Ilaria Rocco; Anna Garuti; Sebastian Wesselborg; Claus Belka; Peter Brossart; Franco Patrone; Alberto Ballestrero
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis.
Blood 2005;105(8):3255-62.
2005: Christopher P Dillon; Peter Sandy; Alessio Nencioni; Stephan Kissler; Douglas A Rubinson; Luk Van Parijs
Rnai as an experimental and therapeutic tool to study and regulate physiological and disease processes.
Annual review of physiology 2005;67():147-73.
2004: Alessio Nencioni; Peter Sandy; Christopher P Dillon; Stephan Kissler; Peter Blume-Jensen; Luk Van Parijs
RNA interference for the identification of disease-associated genes.
Current opinion in molecular therapeutics 2004;6(2):136-40.
2004: Alberto Ballestrero; Alessio Nencioni; Davide Boy; Ilaria Rocco; Anna Garuti; Giuseppe Sandro Mela; Luk Van Parijs; Peter Brossart; Sebastian Wesselborg; Franco Patrone
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1463-70.
2004: Alessio Nencioni; F Grüenbach; Franco Patrone; Peter Brossart
Anticancer vaccination strategies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15 Suppl 4():iv153-60.
2004: Alessio Nencioni; Peter Brossart
Cellular immunotherapy with dendritic cells in cancer: current status.
Stem cells (Dayton, Ohio) 2004;22(4):501-13.
2003: Alessio Nencioni; Kirsten Lauber; Frank Grünebach; Luk Van Parijs; Claudio Denzlinger; Sebastian Wesselborg; Peter Brossart
Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(10):5148-56.
2003: Martin R Müller; Frank Grünebach; Katrin Kayser; Wichard Vogel; Alessio Nencioni; Wolfram Brugger; Lothar Kanz; Peter Brossart
Expression of her-2/neu on acute lymphoblastic leukemias: implications for the development of immunotherapeutic approaches.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3448-53.
2003: Katrin Layer; Guosheng Lin; Alessio Nencioni; Wei Hu; Adam Schmucker; Andrey N Antov; Xiaoyu Li; Satoshi Takamatsu; Timothy Chevassut; Nancy A Dower; Stacey L Stang; David Beier; Janet Buhlmann; Roderick T Bronson; Keith B Elkon; James C Stone; Luk Van Parijs; Bing Lim
Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1.
Immunity 2003;19(2):243-55.
2003: Martin R Müller; Frank Grünebach; Alessio Nencioni; Peter Brossart
Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(12):5892-6.
2003: Alessio Nencioni; Martin R Müller; Frank Grünebach; Anna Garuti; Maria Cristina Mingari; Franco Patrone; Alberto Ballestrero; Peter Brossart
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer.
Cancer gene therapy 2003;10(3):209-14.
2003: Frank Grünebach; Martin R Müller; Alessio Nencioni; Peter Brossart
Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes.
Gene therapy 2003;10(5):367-74.
2003: Alessio Nencioni; Sebastian Wesselborg; Peter Brossart
Role of peroxisome proliferator-activated receptor gamma and its ligands in the control of immune responses.
Critical reviews in immunology 2003;23(1-2):1-13.
2002: Alessio Nencioni; Kirsten Lauber; Frank Grünebach; Wolfram Brugger; Claudio Denzlinger; Sebastian Wesselborg; Peter Brossart
Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli.
Experimental hematology 2002;30(9):1020-8.
2002: Alessio Nencioni; Frank Grünebach; Anke Zobywlaski; Claudio Denzlinger; Wolfram Brugger; Peter Brossart
Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(3):1228-35.
2001: Alberto Ballestrero; Domenico A Coviello; Anna Garuti; Alessio Nencioni; A Famà; Ilaria Rocco; Roberto Bertorelli; Fabio Ferrando; Roberta Gonella; Franco Patrone
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination.
Cancer 2001;92(8):2030-5.
2001: Alessio Nencioni; Peter Brossart
New perspectives in dendritic cell-based cancer immunotherapy.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2001;15(10):667-79.